Our Pricing

Best Weight Loss Injections - Available Now UK

Finding the best weight loss injections UK pharmacies offer requires understanding how each treatment works and which suits your clinical needs. At Cured Pharmacy, our UK-registered clinical team provides access to all three licensed injectable treatments—Mounjaro, Wegovy, and Saxenda—with transparent upfront pricing and expert guidance throughout your weight management journey.

How Injectable Weight Loss Treatments Work

The best weight loss injections UK patients can access belong to a class of medications called GLP-1 receptor agonists, which mimic natural hormones that regulate appetite and blood sugar levels [1]. These treatments work by slowing gastric emptying, reducing hunger signals to the brain, and improving insulin sensitivity—mechanisms that support sustained weight reduction when combined with lifestyle modifications.

Mounjaro (tirzepatide) represents the newest generation, functioning as a dual GIP/GLP-1 receptor agonist. This dual-pathway approach produced superior results in clinical trials, with participants achieving an average 22.5% body weight reduction over 72 weeks on the highest dose [2]. Wegovy (semaglutide) and Saxenda (liraglutide) are single-pathway GLP-1 agonists, both MHRA-licensed and clinically proven, though with different dosing schedules and efficacy profiles.

All three treatments are prescription-only medications in the UK and require clinical assessment by a registered prescriber before dispensing. Your suitability depends on your BMI, medical history, current medications, and weight loss goals—factors our clinical team evaluates during your free online consultation.

Mounjaro (Tirzepatide): The Dual-Action Injectable

Mounjaro has quickly become recognised among the best weight loss injections UK prescribers recommend for patients requiring maximum efficacy. As the first dual GIP/GLP-1 receptor agonist licensed by the MHRA, tirzepatide activates two complementary hormone pathways rather than one, producing greater appetite suppression and metabolic improvement [2].

In the SURMOUNT-1 trial, participants without diabetes achieved up to 22.5% total body weight reduction over 72 weeks—substantially higher than comparator treatments [2]. The once-weekly injection schedule and pre-filled KwikPen delivery system offer convenience, whilst the graduated dose escalation protocol minimises gastrointestinal side effects during the initial treatment phase.

At Cured Pharmacy, Mounjaro starts from £135.00 per pen, with your prescribed dose determined by our UK clinical team based on your individual response and tolerability. The treatment requires ongoing clinical monitoring, and our pharmacists remain available throughout your programme to address questions about injection technique, side effect management, and dose adjustments.

Who Should Consider Mounjaro

Mounjaro may be suitable for adults with a BMI of 30 kg/m² or above, or 27 kg/m² with weight-related health conditions such as hypertension or dyslipidaemia [3]. Your UK prescriber will assess contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease. Patients who have not achieved adequate results with lifestyle interventions alone often find dual-agonist therapy particularly effective, subject to clinical approval.

Wegovy (Semaglutide): The Established Weekly Injectable

Wegovy remains one of the best weight loss injections UK patients have accessed since its MHRA approval, with extensive clinical trial data demonstrating consistent efficacy and safety. Semaglutide works by activating GLP-1 receptors to reduce appetite, slow gastric emptying, and improve glycaemic control in individuals with obesity [4].

The STEP clinical trial programme showed that participants achieved an average 14.9% body weight reduction over 68 weeks when combining Wegovy with lifestyle interventions [4]. The once-weekly subcutaneous injection uses a pre-filled pen similar to Mounjaro, and the dose escalation schedule typically spans 16-20 weeks to reach the maintenance dose of 2.4mg.

Wegovy is available at Cured Pharmacy with competitive UK pricing and includes the same comprehensive clinical support as all our weight management treatments. Patients appreciate the established safety profile, extensive real-world usage data, and the convenience of weekly rather than daily administration.

Wegovy vs Mounjaro: Clinical Differences

Whilst both are weekly injectables licensed for weight management, Mounjaro's dual-receptor mechanism typically produces greater weight reduction in head-to-head comparisons, though individual response varies [2][4]. Wegovy may be preferred for patients with specific contraindications to tirzepatide, those who have previously used GLP-1 treatments successfully, or individuals seeking a treatment with longer real-world safety data. Your UK prescriber will recommend the most appropriate option based on your clinical profile, previous treatment history, and personal preferences during your consultation.

Saxenda (Liraglutide): The Daily Injectable Option

Saxenda offers a daily injection alternative among the best weight loss injections UK pharmacies dispense, using liraglutide at a higher dose than its diabetes formulation. The once-daily administration schedule provides consistent GLP-1 receptor activation throughout the day, which some patients find beneficial for appetite control [5].

Clinical trials demonstrated that Saxenda users achieved an average 8% body weight reduction over 56 weeks when combined with reduced-calorie diet and increased physical activity [5]. Whilst the percentage reduction is lower than weekly alternatives, the daily dosing allows for more granular dose adjustments and may suit patients who prefer frequent, lower-volume injections.

The treatment requires daily subcutaneous injection, typically in the abdomen, thigh, or upper arm. The pre-filled pen delivers doses from 0.6mg during the initial escalation phase up to the maintenance dose of 3.0mg. Patients who have previously used insulin or other injectable medications often adapt quickly to the daily routine, and our clinical team provides comprehensive injection training and ongoing support.

Comparing the Best Weight Loss Injections UK: Efficacy and Tolerability

When evaluating the best weight loss injections UK patients can access, efficacy data from clinical trials provides important context, though individual results vary considerably. Mounjaro demonstrated the highest average weight reduction (up to 22.5%), followed by Wegovy (average 14.9%), then Saxenda (average 8%) in their respective pivotal trials [2][4][5]. However, these figures represent group averages—your personal response depends on adherence, lifestyle modifications, baseline metabolic health, and genetic factors.

Tolerability profiles are similar across all three treatments, with gastrointestinal side effects (nausea, diarrhoea, constipation) being most common, particularly during dose escalation [1]. These effects typically diminish over 4-8 weeks as your body adapts. Serious adverse events are rare but include pancreatitis risk, gallbladder disease, and potential thyroid concerns—all assessed during your clinical consultation.

Cost considerations also influence treatment choice. At Cured Pharmacy, transparent upfront pricing allows you to compare options before your consultation. Weekly injections generally offer better adherence rates than daily alternatives, whilst dual-agonist therapy provides maximum efficacy for patients requiring substantial weight reduction. Your UK prescriber balances these factors against your medical history, budget, and personal preferences to recommend the most suitable treatment.

Starting Weight Loss Injections: The Cured Pharmacy Process

Accessing the best weight loss injections UK regulations permit begins with a clinical assessment by our UK-registered prescribers. The free online consultation takes under three minutes and covers your medical history, current medications, weight loss goals, and any contraindications to GLP-1 or dual-agonist therapy. Our clinical team reviews your responses within hours, and if approved, your prescription is dispensed from our GPhC-registered pharmacy the same day.

All injectable treatments are delivered in discreet packaging with comprehensive patient information leaflets, injection guides, and sharps disposal information. Your first prescription typically includes the starter dose, with follow-up prescriptions adjusted based on your tolerability and clinical response. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), and the wider pharmacy team remain available throughout your treatment for medication reviews, side effect management, and dose optimisation advice.

We recommend regular weight monitoring, dietary modifications, and increased physical activity alongside any injectable treatment—medications support but do not replace lifestyle interventions [1]. Most patients begin seeing appetite reduction within the first week, with measurable weight loss typically evident by week four. Optimal results require several months of consistent use, and our clinical team provides ongoing support to maximise your success whilst minimising side effects.

Ongoing Clinical Support and Monitoring

Unlike some online services, Cured Pharmacy provides continuous clinical oversight throughout your weight management programme. Our UK prescribers conduct regular medication reviews, adjust doses based on your progress, and monitor for any emerging contraindications or drug interactions. You can contact our pharmacy team on (+44) 116 4646009 during business hours for immediate advice, and our online consultation system allows for prescription renewals and dose adjustments without repeated lengthy assessments. This integrated approach ensures you receive the best weight loss injections UK clinical standards require, with the convenience of online access and the safety of traditional pharmacy care.

Scientific References

1. Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., Holst, J. J., Langhans, W., Meier, J. J., Nauck, M. A., Perez-Tilve, D., Pocai, A., Reimann, F., Sandoval, D. A., Schwartz, T. W., ... Tschöp, M. H. (2019). Glucagon-like peptide 1 (GLP-1). Molecular Metabolism, 30, 72–130. https://doi.org/10.1016/j.molmet.2019.09.010
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., Stefanski, A., & SURMOUNT-1 Investigators. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
3. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating overweight and obesity [TA1027]. NICE. https://www.nice.org.uk/guidance/ta1027
4. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., Kushner, R. F., & STEP 1 Study Group. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
5. Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., Lau, D. C., le Roux, C. W., Violante Ortiz, R., Jensen, C. B., Wilding, J. P., & SCALE Obesity and Prediabetes NN8022-1839 Study Group. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, lifestyle modifications, and individual metabolic factors.